NIFTY 50▲24,915.80
120.05 (0.48%)
SENSEX▲81,394.54
344.54 (0.43%)
NIFTY BANK▲50,975.30
496.40 (0.98%)
TATA MOTORS▼911.20
-16.65 (-1.79%)
SUZLON ENERGY▲72.37
1.44 (2.03%)
TATA STEEL▼158.82
-5.54 (-3.37%)
INDIAN RAILWAY FINANCE CORP▲148.95
4.60 (3.19%)
TATA POWER▲454.65
13.35 (3.03%)
RAIL VIKAS NIGAM▲475.85
24.15 (5.35%)
VODAFONE IDEA▲9.35
0.19 (2.07%)
RELIANCE INDUSTRIES▲2,770.60
29.15 (1.06%)
ZOMATO▲275.25
9.15 (3.44%)
INDIAN RENEWABLE ENERGY▲220.48
9.35 (4.43%)
RELIANCE POWER▼45.98
-2.42 (-5.00%)
ADANI POWER▲636.20
10.75 (1.72%)
YES BANK▲21.39
0.13 (0.61%)
STATE BANK OF INDIA▲777.70
7.05 (0.91%)
NHPC▲90.79
0.32 (0.35%)
HDFC BANK▲1,651.65
33.85 (2.09%)
JIO FIN SERVICES LTD▲339.80
3.45 (1.03%)
OLA ELECTRIC MOBILITY LTD▲91.71
0.89 (0.98%)
BHARAT ELECTRONICS▲275.40
8.05 (3.01%)
INDIAN OIL CORP▼162.45
-0.29 (-0.18%)
ADANI PORT & SEZ▲1,400.30
45.10 (3.33%)
GTL INFRA▲2.23
0.04 (1.83%)
MRF▲1,31,449.50
211.65 (0.16%)
JAIPRAKASH POWER VENTURES▲18.74
0.29 (1.57%)
INDIAN RAILWAY TOURISM CORP▲865.10
7.40 (0.86%)
Ajanta Pharma Share Price
AJANTPHARM
₹3,367.50+₹57.50 (1.74%) TodayLast updated on 08 Oct, 2024 | 12:43 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹3,251.50 | Close₹3,310.00 |
Circuit range₹3,972.00 - ₹2,648.00 | Day range₹3,205.20 - ₹3,426.75 | Year range₹1,650.05 - ₹3,485.00 |
Volume3,04,135 | Avg. traded₹3,368.32 | Revenue (12m)₹4,333 Crs |
Ajanta PharmaAjanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.
Ajanta Pharma Key indicators
52 week high₹3,485.00 | 52 week low₹1,650.05 | P/E ratio48.83 |
P/B ratio10.92 | ROE24.26% | ROCE33.15% |
Dividend yield1.53% | Debt/Equity ratio | EPS64.12 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
78%
Hold
11%
Sell
11%
This analysis is based on the reviews of 9 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin30.18% | Net profit margin19.71% |
ROE24.26% | ROA18.68% |
ROCE33.15% |
Learn more
Ajanta Pharma Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Mon, Oct 7 2024 | ₹3,354.25 | ₹3,310.00 | -0.44% |
Fri, Oct 4 2024 | ₹3,340.10 | ₹3,324.75 | -0.78% |
Thu, Oct 3 2024 | ₹3,244.20 | ₹3,350.95 | |
Tue, Oct 1 2024 | ₹3,217.60 | ₹3,253.60 | |
Mon, Sep 30 2024 | ₹3,292.00 | ₹3,201.60 | -3.94% |
Fri, Sep 27 2024 | ₹3,155.10 | ₹3,333.05 | |
Thu, Sep 26 2024 | ₹3,254.55 | ₹3,184.05 | -1.68% |
Wed, Sep 25 2024 | ₹3,199.05 | ₹3,238.35 |
Events
Corporate actions
Dividend • ₹26/share
Ex date 08 Feb 2024
Dividend • ₹15/share
Ex date 04 Aug 2023
Dividend • ₹10/share
Ex date 04 Aug 2023
Dividend • ₹7/share
Ex date 11 Nov 2022
Bonus • 1:2
Ex date 22 Jun 2022
Dividend • ₹9.5/share
Ex date 09 Nov 2021
Learn more